| Home | E-Submission | Sitemap | Editorial Office |  
Journal of Wound Management and Research > Volume 18(3); 2022 > Article
Jun: Pathophysiology and Conservative Treatment of Venous Ulcers: A Review


Defined as an ulceration in a lower extremity caused by venous hypertension, venous ulcers are a common condition which are known to affect approximately 1% of the population. They cause substantial socioeconomic burden and significant impact on patients’ quality of life. Although a number of diagnostic procedures are applicable in diagnosis of venous ulcers, color-flow duplex ultrasound remains the gold standard. For therapeutic options, compression therapy remains the mainstay. Adjunct therapies such as physiotherapy, manual lymphatic drainage, or phlebotonics can be considered to provide symptomatic relieve. This article aims to provide an overview of the anatomy and pathophysiology of venous ulcers as well as their conservative treatment.


Venous ulcers are open skin wounds occurring in regions of the leg or foot affected by venous hypertension [1]. The pathophysiology of venous ulcers is a complex process with various associated signs such as varicose veins, chronic discharge, dermatitis, skin hyperpigmentation and fibrosis. These ulcers generally display a characteristic irregular shape with sharply demarcated borders, and are usually located in the peri-malleolar area [2]. Although ulcer depth is typically limited to the subcutaneous layers, infection can cause extensive deep tissue injury.
The prevalence of venous ulcers ranges from 0.7% to 2% of the general population [35]. They are the most common type of chronic leg ulcers and are three to four times more prevalent than arterial ulcers. Risk factors include old age, obesity, previous trauma history, immobility and genetic thrombophilic conditions such as factor V Leiden mutation [6]. Venous disease is more frequently observed in women [7,8] and pregnancy is known to increase the risk of developing a chronic venous ulcer [9].


Venous anatomy and physiology

An understanding of venous anatomy provides a better comprehension of chronic venous disease. The venous structure of the lower extremities can be categorized into superficial and deep systems. Superficial veins (e.g., greater saphenous vein, lesser saphenous vein and accessory saphenous vein) are located between the dermis and the muscle fascia, whereas deep veins (e.g., femoral vein, common femoral vein, deep femoral vein, popliteal vein, anterior and posterior tibial vein) are located beneath the muscle fascia [10,11]. These deep and superficial venous systems are connected by perforating veins. Most of the venous blood volume–approximately 85%–is reserved in the deep venous system.
Conductivity, capacitance, and directionality are the major components of venous physiology. Conductivity is related to low resistance in venous structures. This feature enables trans-portation of a large volume of blood without high energy ex-penditure. Capacitance refers to how easily the vein wall di-lates. Directionality is enabled by one-way valves in the venous structure generated from three physiological functions: respi-ration, cardiac contraction and locomotion. Venous dysfunction is induced from alteration of any of these three components.

Valve incompetence

A constant unidirectional flow from the superficial into the deep venous system is ensured by competent valves in perforating veins. Superficial veins also must have competent valves to propagate flow into the more proximal deep veins. With incompetent valves, retrograde displacement of blood into the intramuscular veins and sinusoids can occur. This causes im-pediment of arterial inflow and decrease of muscle pump effectiveness (Fig. 1). Therefore, pump effectiveness and the pathways of blood flow direction are determined by the com-petence of venous valves.
Fig. 1.
Illustration of incompetent valves resulting in venous reflex. With competent valves, venous blood flows physiologically from the superficial system to the deep system through perforating veins (left). When damaged valves lose their function, reflux occurs which ultimately leads to venous hypertension (right).


Obstruction is an important factor in the pathogenesis of venous ulcers. Proximal venous obstruction has a higher prevalence in chronic venous disease and implies poorer outcomes in treatment [12]. Marston et al. [13] reported the importance of identifying venous obstruction in venous ulcer patients. Though frequently occurring in post-thrombotic veins, venous obstruction is difficult to detect non-invasively and thus often goes unnoticed. Intravascular ultrasound has proven its efficacy in assessment of the degree and extent of iliac vein ste-nosis compared to ascending phlebography which had previously been considered the standard [14].

Calf muscle pump

The theory of the calf muscle pump concept is a crucial com-ponent of venous physiology. Contraction of the calf muscles causes compression of the deep venous system, resulting in proximal propagation of blood. On the other hand, relaxation of the calf muscles causes expansion of the deep venous system followed by influx of blood from the superficial venous system through perforating veins. Dysfunctional calf muscles could be the prime cause for venous hypertension in some patients. Decreased ankle range of motion is also frequently observed in people with venous ulcers. Patients with chronic venous disease are prone to secondary lymphedema (phlebo-lymphedema) which is usually more severe at the ankle level. Because of restrictions in ankle motion, the effectiveness of the calf muscle pump decreases.

Genetic factors

Genetic mutation can be a predisposing factor for developing venous ulcers. Factor XIII is an important element for the for-mation of a fibrin matrix wound cover, further initiating a cascade of fibroblast growth and migration. Mutation in the F13A1 gene which encodes Factor XIII is known to be associated with increased size of venous leg ulcers and delayed wound healing [15]. A recent publication by Anwar et al. [16] summarized genetic mutations associated with poor healing or progression of venous ulcers.


Venous stasis theory

Introduced in 1917 by Homans [17], the term “postphlebitic syndrome” was used to explain the etiology of venous ulcer-ations. Based on previous literature, he described damaged valves and dilated walls as central elements in venous stasis. Homans hypothesized that hypoxia of the surrounding tissues is induced by this stasis, which ultimately leads to ulceration.

Arteriovenous fistula theory

Blalock [18] postulated the arteriovenous fistula theory from an analysis of hypoxia from chronic venous insufficiency. He compared blood samples from the femoral vein, greater saphenous vein, and varicose veins in patients with chronic venous insufficiency and samples taken from normal limbs. Higher oxygen concentration was noted in proximal veins of affected limbs. Therefore, he hypothesized that increased flow caused by arteriovenous fistulae rather than stasis was the cause of venous ulcers.

Fibrin cuff theory

Proposed by Burnand et al. [19], the fibrin cuff theory is based on a study of skin biopsies from patients with chronic venous disease. The biopsies revealed enlarged capillaries with a notable increase in pericapillary fibrin deposition. The investiga-tors hypothesized that venous hypertension caused microcir-culatory changes that enlarged the endothelial gap junctions, leading to extravasation of serous fluid which would include fibrinogen. The ensuing pericapillary fibrin cuffs would act as a barrier against skin nutrition and oxygenation.

White blood cell trap theory

Early activation of white blood cells resulting from venous hypertension has been demonstrated in previous studies. Coleridge Smith et al. [20] introduced a hypothesis in which white cell trapping results in neutrophil activation, consequentially dam-aging the surrounding tissues. Because white blood cells are known to be important mediators of ischemia and tissue dam-age, this theory is an essential part of the cascade of cellular and humoral events leading to venous ulceration.

Classification and diagnosis


The CEAP (Clinical-Etiological-Anatomical-Pathophysiologi-cal) classification is the current international standard for clas-sifying chronic venous disease [21,22]. The aspects of the classification are summarized in Table 1.
Table 1.
CEAP (Clinical-Etiological-Anatomical-Pathophysiological) classification for chronic venous disease
Clinical Etiology Anatomy Pathophysiology
C0 No visible abnormalities Ep Primary As Superficial Pr Reflux
C1 Telangiectasis or reticular veins Es Secondary Ap Perforating Po Obstruction
C2 Varices Ec Congenital Ad Deep Pr,o Reflux and obstruction
C3 Edema En No venous cause identified An No venous location identified Pn No venous pathophysiology identified
C4 Changes in skin and subcutaneous tissue
  a. Pigmentation or eczema
  b. Lipodermatosclerosis or atrophie blanche
C5 Healed ulcer
C6 Active, open ulcer
S Symptomatic
  Pain, tightness, skin irrigation, heaviness, muscle cramp
A Asymptomatic


The diagnosis of venous ulcers is clinically based on patient history and clinical presentation, augmented when necessary by diagnostic tests. While color-flow duplex ultrasound is currently the gold standard diagnostic procedure for chronic venous disease [10], other examinations can be performed in adjunct to duplex sonography.
The ankle-brachial index (ABI) is a non-invasive test which identifies peripheral arterial disease (PAD) in the lower extremity. If the ABI is less than 0.8, it is mandatory to evaluate and rule out arterial insufficiency because application of compression therapy in such instances can cause detrimental con-sequences.
Duplex ultrasound is a non-invasive examination which combines traditional ultrasound with Doppler ultrasonogra-phy for structural and functional evaluation of the venous system. Both arterial and venous blood flow can be visualized, with easy detection of obstructions and refluxes [23,24]. This also allows mapping of superficial, deep and perforating venous systems.
Photoplethysmography (also called light reflex rheography), also non-invasive, is a test which measures venous refill time. A probe is positioned on the skin just above the ankle, and the patient is instructed to perform brief periods of calf muscle pump exercises. Infrared light reflected by hemoglobin is mea-sured by the probe, assessing skin blood flow reduction caused by exercise [25]. The test measures calf muscle pump efficien-cy while also determining whether abnormal venous reflux is present.
Other imaging modalities such as computed tomography and magnetic resonance imaging can also be utilized. Although not routinely used for venous imaging, they can be used for evaluation of pelvic vein thrombosis due to the diagnostic limitations of duplex ultrasound in intrapelvic structures.


The goal of venous ulcer treatment is to improve symptoms, prevent sequelae, and promote ulcer healing. Compression therapy and ancillary treatment (e.g., physical therapy, manual lymphatic drainage, and phlebotonics) constitute the back-bone of non-surgical venous ulcer treatment.

Compression therapy

The cornerstone of treatment for venous ulcers is medical compression therapy. While being both easy to apply and non-invasive, compression therapy effectively counteracts the mechanism of chronic venous disease (e.g., venous reflux and hypertension); therefore, the importance of compression can never be overstated. The following are examples of medical compression therapy: (1) short-stretch bandages, (2) long-stretch bandages, (3) Non-elastic bandages, (4) multicomponent systems, (5) ulcer stocking systems, and (6) adaptive compression systems.
Table 2 provides an overview of compression devices used in venous ulcer management [26].
Table 2.
Systems for compression therapy
Type Example Self-application Indication Advantage Disadvantage Stiffness
Short-stretch bandages Comprilan No Decongestion phase High working pressure Slipping High
Washable and reusable
Long-stretch bandages Perfekta Yes Decongestion phase Easy application Low working pressure Low
Removed over night
Non-elastic bandages Zinc paste (Unna) No Decongestion phase High working pressure Messy Very high
Well tolerated during rest
Multicomponent system Coban 2, UrgoK2 No Decongestion phase and maintenance phase High working pressure Well tolerated during rest Bulky High
Ulcer stocking system Jobst UlcerCare Yes Maintenance phase Patient can shower and self-manage Difficult donning Moderate
Adaptive compression bandages Actitouch Yes Decongestion phase and maintenance phase Pressure is sustained Patient can shower and self-manage Difficult donning High

Modified from Partsch. Phlebology 2014;29(1 suppl):140-5, with permission of SAGE Publications [26].

Short-stretch bandages have low elasticity (less than 100%). They are usually made of cotton and can provide high working and low resting pressures. A padding layer should preferably be used to prevent slippage (Fig. 2). The bandage should be renewed every morning.
Fig. 2.
Compression method using short-stretch bandages. (A) Materials, (B) tubular gauze, (C) underpadding, and (D) short-stretch bandage application with 50% overlap are displayed.
Long-stretch bandages are composed of cotton, polyamide, elastane and viscose. Because of their high elasticity (more than 100%), long-stretch bandages can provide low working and high resting pressures. As this can lead to pressure injury, using long-stretch bandages exclusively for strong compression is not recommended and overnight application should be avoided [27,28].
Non-elastic bandages such as zinc paste bandages (used in Unna boots) are notable for their very high working pressures and very low resting pressures. Their elasticity is below 10%. Zinc paste bandages consist of elastic fabric drenched in zinc solution or zinc paste. After wrapping the wet bandages around the affected extremity, compression pressure is devel-oped through solidification. The dried bandage becomes rigid and is maintained for several days [29,30].
Multicomponent systems commonly called “four-layer ban-dages” consist of different materials, including padding, compression, and fixation bandages. They provide great tolerability and a visual indicator assists in achieving optimal pressure [31]. Depending on the underlying wound status, these bandages may be maintained for up to 7 days, but more frequent change intervals are required in heavily exuding wounds.
Ulcer stocking systems are usually made of two components: an understocking and an outer compression stocking. After training, many patients can readily apply them on their own (Fig. 3). The ulcer stocking system represents the treatment option of choice during the maintenance phase.
Fig. 3.
Compression method using ulcer stocking systems. (A) Material, (B) tubular gauze, and (C) ulcer stocking application are displayed.
Adaptive compression systems are also known as wrap systems or Velcro systems. These consist of short stretch material fixed by Velcro bands. Pressure can be adjusted at need to a comfortable level by the patient [32].
To properly understand the effects of compression therapy, one must know the distinction between resting and working pressure (Fig. 4). Resting pressure is defined as the pressure applied to the extremity at rest. This correlates to the strain exerted by the compression garment on relaxed muscles. Working pressure is a collaboration of both muscle contraction and external compression when the extremity is moving and muscles working. Therefore, the goal of compression therapy is to minimize the resting pressure and maximize the working pressure.
Fig. 4.
Illustration of comparison between resting and working pressure. Resting pressure refers to constant external pressure applied to skin and venous systems generated by the pressure garment (left). Working pressure refers to a dynamic pressure exerted on skin and venous systems generated from the combination of muscle contraction forces and the pressure garment (right).
Compression should be adjusted according to treatment stage, which can be divided into the decongestion phase and the maintenance phase. Edema control and promotion of ulcer healing are the primary aims in the decongestion phase. In this period strong compression methods, such as short-stretch bandages or multicomponent bandages, can be applied. Because of profuse edema and discharge, a combination of high absorbent wound dressings with daily renewal of bandages is generally recommended. Over time, decrease in exudate and congestion will allow twice-weekly bandage changes [28]. Completion of the decongestion phase leads to the maintenance phase. Compression during the maintenance phase can be successfully carried out by ulcer stocking systems [33]. However, protective padding should be applied to the edges of the tibia, the fibula head, and the ankle region with caution to prevent pressure injuries.
There is no clear evidence that proves superiority of a par-ticular type of compression. Regardless of the bandage type, it must be properly applied, which requires training [27]. Never-theless, studies suggest that high-pressure compression is more effective than low-pressure compression; and multiple layers of bandage may be necessary for adequate compression [3436].
Some critical contraindications should be considered before applying compression therapy [27,28]. Absolute contraindications include advanced PAD, decompensated heart failure, and septic phlebitis. Relative contraindications include mild to moderate PAD, advanced peripheral polyneuropathy, chronic compensated heart failure, allergic reactions or intolerance to compression system materials, and treatment-related pain.


The goal of physiotherapy is to decrease venous pressure and edema by increasing calf muscle pump function through exercise or biomechanical stimulation. Lifestyle changes and spe-cial exercises can help in improving both calf muscle function and ankle mobility. Klyscz et al. [37] reported the benefits pro-duced by a venous rehabilitation program including four phases of training (warming, bike exercises, walking and relaxation). Another study that reviewed 16 papers concluded that increased physical activity, improved mobility, and foot exercises have a beneficial impact on lowering recurrence of venous ulcers [38].

Manual lymphatic drainage

Manual lymphatic drainage by massaging is a well-established therapy for lymphedema patients. This method increases both the transport capacity of the lymphatics and peripheral circu-lation [39]. One study reported that manual lymphatic drainage improved ankle joint mobility in venous ulcer patients with but did not improve wound healing [40]. Although there is currently a lack of supporting evidence, manual lymphatic drainage is a potential adjunctive treatment in some resistant ulcers.


Drugs such as natural flavonoids (e.g., rutoside, French mari-time pine bark extract, grape seed extract, etc.) and similar synthetic products (e.g., calcium dobesilate, naftazone, amin-aftone, chromocarbe) which are known to improve blood cir-culation are collectively referred to as venoactive drugs or phlebotonics. These agents are used to relieve symptoms such as pain, paresthesia, or restless leg but have no reported effect on ulcer healing [41]. Therefore, phlebotonics can be considered as an adjunct therapy to relieve related symptoms. It has been reported that a micronized purified flavonoid fraction (Daflon 500; Servier, Paris, France) reduces edema and related symptoms in chronic venous insufficiency [42]. A double blind placebo-controlled randomized study conducted in 2002 on coumarin and troxerutin (a flavonoid) revealed im-provement in edema control over placebo [43].

Novel therapies

Matrix metalloproteinases play a critical role in venous ulcer pathophysiology. Imbalance between proteinase activity and inhibition is a major cause of delayed wound healing in venous ulcers [44]. Due to the complexity of the molecular mechanism of venous ulcers, developing therapeutic targets has not been easy. A 2008 study demonstrated reduction of protease activity in venous ulcer exudate when a dressing product con-sisting of a combination of collagen and regenerated cellulose (Promogran; Johnson & Johnson, New Brunswick, NJ, USA) was applied [45]. The nano-oligosaccharide factor is a com-pound that promotes wound healing by inhibiting matrix me-talloproteinase activity. A randomized trial including 117 patients was conducted to compare a nano-oligosaccharide fac-tor treatment and Promogran treatment group [46]. The study concluded a promising effect of nano-oligosaccharide factor in treating chronic venous ulcers.


Venous ulcers are a common condition caused by venous reflux and obstruction ultimately resulting in venous hypertension. Numerous theories have been proposed to explain the pathogenesis of venous hypertension causing ulceration from structural to molecular levels. Based on CEAP classification, venous ulcers are clinically diagnosed, but color-flow duplex ultrasound remains the gold standard of all diagnostic modalities. Although a wide range of therapeutic options exist, compression therapy is the fundamental principle that can be applied in all disease stages. Adjunct therapies such as physiotherapy, manual lymphatic drainage, and phlebotonics can be considered to provide symptomatic relief.

Conflict of Interest

No potential conflict of interest relevant to this article was reported.


1. O'Donnell TF Jr, Passman MA, Marston WA, et al. Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2014;60(2 Suppl):3S-59S.
crossref pmid
2. Lal BK. Venous ulcers of the lower extremity: definition, epidemiology, and economic and social burdens. Semin Vasc Surg 2015;28:3-5.
crossref pmid
3. Ruckley CV, Evans CJ, Allan PL, et al. Chronic venous insufficiency: clinical and duplex correlations: the Edinburgh Vein Study of venous disorders in the general population. J Vasc Surg 2002;36:520-5.
crossref pmid
4. Dissemond J, Korber A, Grabbe S. Differential diagnoses in leg ulcers. J Dtsch Dermatol Ges 2006;4:627-34.
5. Goldman MP, Fronek A. Consensus paper on venous leg ulcer. J Dermatol Surg Oncol 1992;18:592-602.
crossref pmid
6. Santler B, Goerge T. Chronic venous insufficiency: a review of pathophysiology, diagnosis, and treatment. J Dtsch Dermatol Ges 2017;15:538-56.
crossref pmid pdf
7. Criqui MH, Jamosmos M, Fronek A, et al. Chronic venous disease in an ethnically diverse population: the San Diego population study. Am J Epidemiol 2003;158:448-56.
crossref pmid pmc
8. Jawien A. The influence of environmental factors in chronic venous insufficiency. Angiology 2003;54(Suppl 1):S19-31.
crossref pmid pdf
9. Rabe E, Pannier-Fischer F, Bromen K, et al. Bonner venenstudie der deutschen gesellschaft für phlebologie. Phlebologie 2003;32:1-14.
10. Cavezzi A, Labropoulos N, Partsch H, et al. Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs: UIP consensus document. Part II. Anatomy. Eur J Vasc Endovasc Surg 2006;31:288-99.
crossref pmid
11. Reich-Schupke S, Stucker M. Nomenclature of the veins of the lower limbs: current standards. J Dtsch Dermatol Ges 2011;9:189-94.
crossref pmid
12. Raju S, Neglen P. High prevalence of nonthrombotic iliac vein lesions in chronic venous disease: a permissive role in pathogenicity. J Vasc Surg 2006;44:136-44.
crossref pmid
13. Marston W, Fish D, Unger J, et al. Incidence of and risk factors for iliocaval venous obstruction in patients with active or healed venous leg ulcers. J Vasc Surg 2011;53:1303-8.
crossref pmid
14. Neglen P, Raju S. Intravascular ultrasound scan evaluation of the obstructed vein. J Vasc Surg 2002;35:694-700.
crossref pmid
15. Tognazzo S, Gemmati D, Palazzo A, et al. Prognostic role of factor XIII gene variants in nonhealing venous leg ulcers. J Vasc Surg 2006;44:815-9.
crossref pmid
16. Anwar MA, Georgiadis KA, Shalhoub J, et al. A review of familial, genetic, and congenital aspects of primary varicose vein disease. Circ Cardiovasc Genet 2012;5:460-6.
crossref pmid
17. Homans J. The etiology and treatment of varicose ulcer of the leg. Surg Gynecol Obstet 1917;24:300-11.

18. Blalock A. Oxygen content of blood in patients with varicose veins. Arch Surg 1929;19:898-905.
19. Burnand KG, Whimster I, Naidoo A, et al. Pericapillary fibrin in the ulcer-bearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration. Br Med J (Clin Res Ed) 1982;285:1071-2.
crossref pmid pmc
20. Coleridge Smith PD, Thomas P, Scurr JH, et al. Causes of venous ulceration: a new hypothesis. Br Med J (Clin Res Ed) 1988;296:1726-7.
crossref pmid pmc
21. Eklof B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004;40:1248-52.
crossref pmid
22. Kistner RL, Eklof B, Masuda EM. Diagnosis of chronic venous disease of the lower extremities: the “CEAP” classification. Mayo Clin Proc 1996;71:338-45.
crossref pmid
23. Goodacre S, Sampson F, Thomas S, et al. Systematic review and meta-analysis of the diagnostic accuracy of ultraso-nography for deep vein thrombosis. BMC Med Imaging 2005;5:6.
crossref pmid pmc pdf
24. Labropoulos N, Tiongson J, Pryor L, et al. Definition of venous reflux in lower-extremity veins. J Vasc Surg 2003;38:793-8.
crossref pmid
25. Nicolaides AN, Miles C. Photoplethysmography in the assessment of venous insufficiency. J Vasc Surg 1987;5:405-12.
crossref pmid
26. Partsch H. Compression for the management of venous leg ulcers: which material do we have? Phlebology 2014;29(1 suppl):140-5.
crossref pmid pdf
27. Neumann M, Cornu-Thenard A, Junger M, et al. Evi-dence-based (S3) guidelines for diagnostics and treatment of venous leg ulcers. J Eur Acad Dermatol Venereol 2016;30:1843-75.
crossref pmid pdf
28. Dissemond J, Assenheimer B, Bultemann A, et al. compression therapy in patients with venous leg ulcers. J Dtsch Dermatol Ges 2016;14:1072-87.
crossref pmid pdf
29. de Abreu AM, de Oliveira BG. A study of the Unna Boot compared with the elastic bandage in venous ulcers: a randomized clinical trial. Rev Lat Am Enfermagem 2015;23:571-7.
crossref pmid pmc
30. Gao AL, Cole JG, Stoecker WV. Unna boot central gauze technique for chronic venous leg ulcers. Dermatol Online J 2017;23:13030/qt3hq040t9.
crossref pmid
31. Moffatt C, Kommala D, Dourdin N, et al. Venous leg ulcers: patient concordance with compression therapy and its impact on healing and prevention of recurrence. Int Wound J 2009;6:386-93.
crossref pmid pmc
32. Damstra RJ, Partsch H. Prospective, randomized, controlled trial comparing the effectiveness of adjustable compression Velcro wraps versus inelastic multicomponent compression bandages in the initial treatment of leg lymphedema. J Vasc Surg Venous Lymphat Disord 2013;1:13-9.
crossref pmid
33. O'Meara S, Tierney J, Cullum N, et al. Four layer bandage compared with short stretch bandage for venous leg ulcers: systematic review and meta-analysis of randomised controlled trials with data from individual patients. BMJ 2009;338:b1344.
crossref pmid pmc
34. Scriven JM, Taylor LE, Wood AJ, et al. A prospective randomised trial of four-layer versus short stretch compression bandages for the treatment of venous leg ulcers. Ann R Coll Surg Engl 1998;80:215-20.
pmid pmc
35. Kurz X, Kahn SR, Abenhaim L, et al. Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management: summary of an evidence-based report of the VEINES task force. Venous Insufficiency Epidemiologic and Economic Studies. Int Angiol 1999;18:83-102.
36. Fletcher A, Cullum N, Sheldon TA. A systematic review of compression treatment for venous leg ulcers. BMJ 1997;315:576-80.
crossref pmid pmc
37. Klyscz T, Junger M, Rassner G. Physical therapy of the ankle joint in patients with chronic venous incompetence and arthrogenic congestive syndrome. Curr Probl Dermatol 1999;27:141-7.
crossref pmid
38. Brown A. Lifestyle advice and self-care strategies for venous leg ulcer patients: what is the evidence? J Wound Care 2012;21:342-50.
crossref pmid
39. Williams A. Manual lymphatic drainage: exploring the history and evidence base. Br J Community Nurs 2010;15:S18-24.
crossref pmid
40. Pereira de Godoy JM, Braile DM, de Fatima Guerreiro Godoy M. Lymph drainage in patients with joint immobility due to chronic ulcerated lesions. Phlebology 2008;23:32-4.
crossref pmid pdf
41. Martinez-Zapata MJ, Vernooij RW, Uriona Tuma SM, et al. Phlebotonics for venous insufficiency. Cochrane Database Syst Rev 2016;4:CD003229.
crossref pmid pmc
42. Nicolaides AN. From symptoms to leg edema: efficacy of Daflon 500 mg. Angiology 2003;54(Suppl 1):S33-44.
crossref pmid pdf
43. Vanscheidt W, Rabe E, Naser-Hijazi B, et al. The efficacy and safety of a coumarin-/troxerutin-combination (SB-LOT) in patients with chronic venous insufficiency: a double blind placebo-controlled randomised study. Vasa 2002;31:185-90.
crossref pmid
44. Mwaura B, Mahendran B, Hynes N, et al. The impact of differential expression of extracellular matrix metallopro-teinase inducer, matrix metalloproteinase-2, tissue inhibi-tor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers. Eur J Vasc Endovasc Surg 2006;31:306-10.
crossref pmid
45. Smeets R, Ulrich D, Unglaub F, et al. Effect of oxidized regenerated cellulose/collagen matrix on proteases in wound exudate of patients with chronic venous ulceration. Int Wound J 2008;5:195-203.
pmid pmc
46. Schmutz JL, Meaume S, Fays S, et al. Evaluation of the na-no-oligosaccharide factor lipido-colloid matrix in the local management of venous leg ulcers: results of a randomised, controlled trial. Int Wound J 2008;5:172-82.
crossref pmid pmc
PDF Links  PDF Links
PubReader  PubReader
ePub Link  ePub Link
XML Download  XML Download
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Related article
Editorial Office
Department of Plastic & Reconstructive Surgery, Dankook University Hospital
201 Manghyang-ro, Dongnam-gu, Cheonan 31116, Korea
TEL: +82-41-550-6285   FAX: +82-41-556-0524   E-mail: office@jwmr.org
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Wound Management Society.                 Developed in M2PI
Close layer
prev next